|
December 6, 2005 Categories: Blogroll Posted by admin
MENLO PARK, Calif., May 10 /PRNewswire-FirstCall/ — Conor Medsystems, Inc. (Nasdaq: CONR) today announced that its UniStar(TM) cobalt chromium bare-metal coronary stent received CE Mark approval in the European Community for the treatment of de novo coronary artery lesions. Conor also announced today that the company has received ISO certification of its facility in Athlone, Ireland for the commercial manufacturing of its proprietary coronary stents including the UniStar stent and the CoStar(TM) cobalt chromium paclitaxel-eluting coronary stent.
Full Press Release
|
|
